Skip to main content

12 Result(s)

within N Zojer Remove this filter Cancer Research Remove this filter

and

  1. Article

    Open Access

    A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

    This randomized, phase III, open-label, multicenter study compared carfilzomib monotherapy against low-dose corticosteroids and optional cyclophosphamide in relapsed and refractory multiple myeloma (RRMM). Rel...

    R Hájek, T Masszi, M T Petrucci, A Palumbo, L Rosiñol, A Nagler, K L Yong… in Leukemia (2017)

    Download PDF (1130 KB) View Article

  2. No Access

    Article

    Exome sequencing in tracking clonal evolution in multiple myeloma following therapy

    N Weston-Bell, J Gibson, M John, S Ennis, S Pfeifer, T Cezard, H Ludwig… in Leukemia (2013)

  3. Article

    Erratum: Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients

    Correction to: Leukemia (2013) 27, 213–219; doi:10.1038/leu.2012.197 Since the publication of this article, the authors have noticed an error within Figure 1, namely that the data for the IgG and IgA patients ...

    H Ludwig, D Milosavljevic, N Zojer, J M Faint, A R Bradwell, W Hübl… in Leukemia (2013)

    Download PDF (164 KB) View Article

  4. Article

    Open Access

    Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients

    The novel heavy/light chain (HLC) assay was used for the detection and measurement of monoclonal immunoglobulins, response evaluation and prognostication. This test allows identification and quantification of ...

    H Ludwig, D Milosavljevic, N Zojer, J M Faint, A R Bradwell, W Hübl… in Leukemia (2013)

    Download PDF (2314 KB) View Article

  5. No Access

    Article

    Evaluating the clonal hierarchy in light-chain multiple myeloma: implications against the myeloma stem cell hypothesis

    S Pfeifer, M Perez-Andres, H Ludwig, S S Sahota, N Zojer in Leukemia (2011)

  6. No Access

    Article

    DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma

    We previously described PASD1 as a new cancer testis antigen in multiple myeloma (MM) that is retained post-therapy, suggesting the use of vaccination strategies to induce anti-PASD1 immunity in a setting of m...

    D Joseph-Pietras, Y Gao, N Zojer, K Ait-Tahar, A H Banham, K Pulford, J Rice… in Leukemia (2010)

  7. No Access

    Article

    Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma

    D Heintel, N Zojer, M Schreder, K Strasser-Weippl, B Kainz, M Vesely… in Leukemia (2008)

  8. No Access

    Article

    IgM-expressing Waldenstrom's macroglobulinemia tumor cells reveal a potential for isotype switch events in vivo

    G Babbage, M Townsend, N Zojer, I C Mockridge, R Garand, B Barlogie… in Leukemia (2007)

  9. No Access

    Article

    Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion

    Studies of bortezomib in patients with relapsed multiple myeloma (MM) suggested that bortezomib may be active even in the presence of adverse prognostic factors. We therefore evaluated 62 patients with relapse...

    V Sagaster, H Ludwig, H Kaufmann, V Odelga, N Zojer, J Ackermann, E Küenburg… in Leukemia (2007)

  10. No Access

    Article

    Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance

    Since deletion of chromosome 13q is a clinically relevant feature in multiple myeloma (MM), we analyzed bone marrow plasma cells from 29 patients with monoclonal gammopathy of undetermined significance (MGUS) ...

    R Königsberg, J Ackermann, H Kaufmann, N Zojer, E Urbauer, E Krömer, U Jäger… in Leukemia (2000)

  11. No Access

    Article

    Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects

    To date, cytogenetic studies on pancreatic carcinoma are rare, and little is known about the frequency of cytogenetic aberrations in primary carcinomas compared with metastatic tumour cells. We therefore evalu...

    N Zojer, M Fiegl, L Müllauer, A Chott, S Roka, J Ackermann… in British Journal of Cancer (1998)

  12. No Access

    Article

    Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients

    In diagnostic evaluation of effusions, difficulties are encountered when atypical reactive mesothelial cells have to be differentiated from malignant cells. We tested the impact of fluorescence in situ hybridi...

    N Zojer, M Fiegl, J Angerler, L Müllauer, A Gsur, S Roka… in British Journal of Cancer (1997)